During the past 30 years, Mr. Yossi Bornstein has played key roles in the Israeli biomed industry.
He was the General Manager of Bristol-Myers Squibb (Israel).
Mr. Bornstein is the CEO and the founder of Shizim Group, a life science holding company. He is the Founder of ShizimXL & ShizimVS, international innovation centers for medical devices & digital health. He is the Chairman of GCP Clinical Studies Ltd., one of the top providers of clinical research services and educational programs in Israel. He served as the Biotechnology Committee Chairman of the United States-Israel Science & Technology Commission (the “USISTC”). Mr. Bornstein is the founder of ILSI – Israel Life Science Industry Organization (who was integrated into IATI) and Founder of ITTN – Israel Tech Transfer Organization. He is a Co-Founder and director of Microbot Medical (NASDAQ: MBOT)